|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.00 EUR | +0.07% |
|
+2.96% | +9.22% |
| 06:11am | Zymeworks to buy Theravance for $929 million in push to expand beyond cancer | RE |
| 04:42am | RBC ups Central Asia Metals to 'sector perform' | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,077B | |||||
| 613B | |||||
| 448B | |||||
| 332B | |||||
| 293B |
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
